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ABSTRACT
Domain III of dengue virus E protein (DIII) participates in the recognition of cell receptors and in structural rearrangements required
formembrane fusion andultimately viral infection; furthermore, it contains epitopes for neutralizing antibodies andhas been consid-
ered a potential vaccination agent. In thiswork, we addressed various structural aspects ofDIII and their relevance for both the dengue
virus infectionmechanismand antibody recognition.Weprovided a dynamic description ofDIII at physiological and endosomal pHs
and in complexwith the neutralizing human antibodyDV32.6.We observed conformational exchange in the isolatedDIII, in regions
important for the packing of E protein dimers on the virus surface. This conformational diversity is likely to facilitate the partial de-
tachment ofDIII from the other E protein domains, which is required to achieve fusion to the host cellularmembranes and to expose
the epitopes ofmany anti-DIII antibodies. A comparison ofDIII of twodengue virus serotypes revealedmany common features but
also somepossibly unexpected differences. Antibody binding toDIII of dengue virus serotype 4 attenuated the conformational ex-
change in the epitope region but, surprisingly, generated exchange in other parts ofDIII through allosteric effects.
IMPORTANCE
Many studies have provided extensive structural information on the E protein and particularly on DIII, also in complex with
antibodies. However, there is very scarce information regarding the molecular dynamics of DIII, and almost nothing is available
on the dynamic effect of antibody binding, especially at the quantitative level. This work provides one of the very rare descrip-
tions of the effect of antibody binding on antigen dynamics.
Dengue virus (DENV) is a member of the Flaviviridae family,which includes yellow fever, West Nile, Japanese tick-borne
encephalitis, and other viruses. DENV is responsible for500,000
hospitalizations and 20,000 deaths per year (1). The incidence
and geographic expansion of the virus are constantly increasing,
and no cure or licensed vaccine is currently available for Dengue
disease. There are four Dengue virus serotypes, DENV1 to -4, and
secondary infection with a different serotype is associated with a
severe form of the disease: dengue hemorrhagic fever (2). This is
probably facilitated by a process called antibody-dependent en-
hancement (ADE), where cross-reactive, poorly neutralizing an-
tibodies allow infection of Fc receptor-bearing cells, leading to
increased viral loads and infectivity (3).
Flaviviruses recognize their target cells via the interaction of
glycoprotein E (E protein) with host receptors, which include the
extracellular matrix components (4–6). After virus internalization
by endocytosis, exposure to the lower endosomal pH leads to al-
terations of the E protein structure, exposing the fusion peptide
and allowing it to interact with the endosome membrane and
mediate viral fusion (1, 7–9).
The virus surface is formed by 180 units of antiparallel E pro-
tein dimers (1, 7, 10, 11). Crystal structures showed that the ect-
odomain of E is formed by three domains (domain I [DI], DII, and
DIII): DII contains the main dimerization interface, glycosylation
sites, and the fusion peptide. DIII, in the C-terminal region of E,
covers the fusion peptide of a neighboring dimer molecule and is
linked to DI by a loop that mediates a large interdomain rear-
rangement during the cell membrane fusion process. DIII is also
supposedly involved in host cell receptor recognition. This do-
main adopts an immunoglobulin-like fold with six -strands
forming two -sheets (ABD and CEF) (12–14). The structure is
well conserved among DENV serotypes and other flaviviruses,
despite DIII being the region with the highest sequence variability.
The E protein is the target of many neutralizing antibodies and a
major component of the natural immune response to dengue vi-
rus (15–18). Antibodies against DIII have been shown to be potent
but not broad neutralizers, supposedly due to such variability.
Conformational flexibility on the E protein plays a significant
role in antibody recognition (19). Indeed, all DIII antibodies with
a known structure recognize epitopes that are only partially acces-
sible on the mature viral surface (20). This might explain why
none of these antibodies is particularly potent, since virus binding
probably requires relatively rare structural motions which briefly
expose the epitopes. Cryo-electron microscopy (cryo-EM) and
X-ray crystallography showed different E protein conformations
when bound by an antibody, suggesting that the antibody can
either induce a conformational change in the E protein or select an
existing, albeit rare, conformation.
The data described above suggest that not only the primary
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sequence and tertiary structure but also differences in molecular
dynamics occurring on the DENV surface can impact epitope ac-
cessibility, binding, and, consequently, the neutralization proper-
ties and serotype specificity of antibodies. Despite DIII being con-
sidered an attractive target for both vaccine and antiviral design
(21–26), the effects of its atomic-level motions on the molecular
mechanisms leading to virus infection and antibody recognition
have been largely neglected. Indeed, antibody-antigen structures
are usually explored by X-ray crystallography, which, by its own
nature, tends to overlook dynamic effects.
In this work, we studied the structure and molecular dynamics of
DIII, highlighting their role in the molecular mechanisms of virus
infection and antibody recognition. Using a combination of nuclear
magnetic resonance (NMR) experiments, we characterized, at the
residue level, the motion of DIII free in solution, at different pHs, and
in complex with a neutralizing human antibody.
MATERIALS AND METHODS
Dengue virus DIII and DV32.6 single-chain variable-fragment (scFv)
antibody production and purification. DIII from the E protein of each
DENV serotype was expressed in Escherichia coli Rosetta cells with a
pET21 vector (Novagen) in M9 minimal medium, using aptly labeled
nutrients (NH4Cl and glucose) as the sole sources of nitrogen and carbon,
as described previously (27).
The DV32.6 single-chain antibody was expressed inE. coliRosetta cells
with a pET21 vector (Novagen) in LB medium. The cells were harvested 5
h after induction, which was done at an optical density at 600 nm (OD600) of
0.7. After sonication and centrifugation, the pellet was repeatedly washed and
centrifuged in a solution containing 50 mM morpholineethanesulfonic acid
(MES) (pH 6.5), 100 mM NaCl, 0.5 mM dithiothreitol (DTT), and 1% Triton
X-100. The pellet was finally resuspended in a solution containing 50 mM
MES (pH 6.5), 6 M guanidinium chloride, and 1 M NaCl (solubilization
buffer). Following the addition of 0.2% polyethyleneimine (PEI) and centrif-
ugation, 65% ammonium sulfate was added to the supernatant. After centrif-
ugation, the pellet was resuspended in solubilization buffer and loaded onto a
HiTrap chelating column (GE). Finally the eluted sample was refolded in a
solution containing 20 mM NaP (pH 7.5), 100 mM NaCl, 200 mM arginine,
1 mM reduced glutathione, and 0.1 mM oxidized glutathione for 18 h at 4°C;
concentrated with Vivaspin concentrators (Sartorius); and further purified
on a Superdex-75 size exclusion column (GE) with the buffer used for NMR
spectroscopy.
NMR spectroscopy. NMR experiments were carried out on Bruker
Avance III 800-MHz spectrometer equipped with a 5-mm triple-resonance
probe and on a Bruker Avance III 600-MHz spectrometer equipped with a
5-mm triple-resonance cryogenic probe. The 1H-15N heteronuclear single
quantum coherence (HSQC) spectra of DIII of DENV1 (DIII-1) and DENV4
(DIII-4) were assigned by using NMR chemical shifts deposited in the Bio-
logical Magnetic Resonance Bank (BMRB; http://www.bmrb.wisc.edu) (ac-
cession numbers 15782 for DIII-1 and 7082 for DIII-4). Triple-resonance
experiments were performed to complete the assignment of DIII-4 by using
260 M 15N,13C-labeled DIII-4 in a solution containing 20 mM phosphate
buffer (pH 6.0) and 50 mM NaCl at 308 K. All data from NMR experiments
were processed by using Topspin 2.1 (Biospin; Bruker) and NMRpipe (28)
and analyzed with the program CCPN (29).
Molecular dynamics of DIII-1 and DIII-4 fromNMR relaxation ex-
periments. The backbone molecular dynamics of DIII-1 and DIII-4 were
characterized by 15N-NMR relaxation experiments using 260 M DIII-1
and DIII-4 at 308 K. 15N R1 (longitudinal) and R2 (transversal) relaxation
rates were obtained by fitting the intensities of NMR peaks in spectra
acquired with different delay times. In R1 experiments, delay times of 50,
100, 200, 300, 400, 600, 800, 1,000, and 1,500 ms were used. Values of 17,
34, 51, 85, 119, 135, 159, 170, 203, and 237 ms were used to calculate R2
ratios. 1H-15N steady-state heteronuclear nuclear Overhauser effects
(NOE) were calculated from peak intensities in spectra acquired with and
without saturation of amide protons (30–32). The relaxation rates were
analyzed with reduced spectral density formalism (33, 34), using the pro-
gram Relax (35, 36), and with the theoretical formalism of Lipari and
Szabo (37), using the program Tensor 2.0 (38). The diffusion correlation
time, c, which reflects the global tumbling of the protein, was calculated
from the R2/R1 ratio by using the isotropic diffusion model. Residues
showingR2 values higher than the average plus the standard deviation and
NOE values lower than 0.65 were excluded from the analysis. Diffusion
tensors were also calculated by using the axial symmetric diffusion model.
This model was used for calculating the internal molecular dynamics pa-
rameters order parameter, S2, and conformational exchange ratio, Rex
(per second), which reflects movements of the NOH bond in picosecond-
to-nanosecond and microsecond-to-millisecond time scales, respectively.
The molecular dynamics of DIII-1 and DIII-4 complexed with scFv
was also analyzed by using R1 and R2 ratios. Data in the experiments were
acquired by using delay times of 50, 100, 200, 300, 500, 700, and 900 ms for
R1 and 17, 34, 51, 68, 85, and 119 ms for R2.
pH variation NMR experiments. The effect of pH variation from 5.5
to 7.2 on the structure of DIII-4 was assessed by chemical shift perturba-
tion of amide 1H and 15N obtained from 1H-15N HSQC experiments
carried out at both pHs. The chemical shift perturbation (CSP) index was
calculated by using the formula: CSP H20.1N2 here, H
and N are the chemical shift differences in the 1H and 15N dimensions,
respectively. The transversal relaxation rates, R2, of amide
15N of DIII-4
were also calculated to monitor the molecular dynamics changes caused
by pH variation. In these experiments, the same delay time values men-
tioned above for the Lipari-Szabo analysis were used. All experiments
were performed by using 100 M DIII-4 in a solution containing 20 mM
phosphate buffer, 2 mM sodium azide, and 50 mM NaCl at 35°C.
Binding of DIII-1 and DIII-4 with scFv DV32.6. The binding of scFv
DV32.6 to DIII-1 and DIII-4 was monitored by using the chemical shift
perturbation index of amide 1H and 15N obtained from comparison of the
HSQC spectra of DIII free and in complex with scFv32.6. The CSP index
was calculated with the same formula mentioned above for pH variation
experiments. All binding experiments were performed by using 260 M
DIII-1 and -4 and 260M DV32.6 in a solution containing 20 mM phos-
phate buffer, 2 mM sodium azide, and 50 mM NaCl (pH 6.0) at 35°C.
Paramagnetic relaxation enhancement experiments.To monitor the
solvent accessibility of residues of DIII-4 in complex with scFv DV32.6,
1H-15N HSQC NMR spectra of 15N isotopically labeled DIII-4 in complex
with scFv DV32.6 were recorded in the presence and in the absence of the
gadolinium-based paramagnetic relaxation agent Gd-diethylenetriamine
pentaacetic acid-bismethylamide [Gd(DTPA-BMA)] (GE Life Science,
Little Chalfont, United Kingdom). The effect of Gd(DTPA-BMA) on the
relaxation rates of the amide 15N nucleus of the DIII-4 –scFv DV32.6
complex was assessed by calculating the difference in the intensities of
NMR resonance on the 1H-15N HSQC of the complex upon the addition
of aliquots of 1 to 10 mM the relaxation agent. In Fig. 2B, the difference in
intensity is denoted as Int Int(Gad). Experiments were performed with
200 M DIII-4 and 200 M DV32.6 in a solution containing 20 mM
phosphate buffer, 2 mM sodium azide, and 50 mM NaCl (pH 6.0) at 35°C.
RESULTS
Comparative molecular dynamics of DIII-1 and DIII-4 deter-
mined by NMR spectroscopy. We used solution NMR spectros-
copy to characterize the molecular dynamics of E protein DIII at
the residue level. NMR is possibly the only experimental tech-
nique that can provide a quantitative measure of residue flexibil-
ity. The general idea is that the rate of NMR signal decay (relax-
ation) is related to the flexibility of the atoms observed (39, 40). In
this work, we used standard NMR pulse sequences to measure 15N
R1,R2, and NOE rates. The global rotational diffusion and internal
movements of 1H-15N bonds in DIII were characterized by using
both Lipari-Szabo formalism and the reduced spectral density
Conformational Diversity in DIII Probed by NMR
February 2016 Volume 90 Number 4 jvi.asm.org 1803Journal of Virology
 o
n







function. Overall, the data allowed us to draw a comprehensive
picture of the dynamic properties of DIII.
A first indication about the experimental reliability is obtained
from the correlation times (c), which depend on the rate at which
molecules tumble in solution. Values for DIII-1 and DIII-4 were
6.1 and 5.7 ns, respectively, using an isotropic model for molecular
rotational diffusion. These values are consistent with the tumbling
of proteins with a molecular mass of10 kDa, such as DIII. Par-
allel and perpendicular components of the rotational diffusion
tensor, D// and D, of 2.5 and 3.0 ns for DIII-1 and 2.8 and 3.1 ns
for DIII-4, respectively, were obtained using axially symmetric
anisotropic diffusion models.
Flexibility within a given residue can be investigated via the
so-called order parameter (S2) and spectral density function
J(	15N). Results for backbone NH atoms show similar behaviors
for DIII-1 and DIII-4. Residues in the N and C termini presented
higher flexibility, as indicated by lower J(	15N) and S
2 values, as
expected for isolated domain fragments. Some residues located in
loops BC, CD, and EF also showed a higher degree of flexibility
than residues in the beta strands (Fig. 1A and C). Despite the
similarity observed in the picosecond-to-nanosecond time scale,
DIII-1 and DIII-4 showed many differences when slower move-
ments (microsecond-to-millisecond time scale) were taken into
account. These slower movements typically indicate exchange be-
tween alternative conformations. Analysis of the exchange rate,
Rex (Fig. 1B and D), and J(0) show contributions from exchange in
the microsecond-to-millisecond time scale, indicated by higher-
than-average values. Residues showing conformational exchange
are indicated by spheres in Fig. 1B.
Intriguingly, the residues with conformational exchange
mapped to different parts of the structure in the two serotypes.
Another difference is related to V320, which presented duplicate
resonances in DIII-1, typically related to a slow conformational ex-
change regime in the NMR chemical shift time scale. The corre-
sponding residue of DIII-4, T320, instead showed a lower signal in-
tensity, which is a typical consequence of line broadening caused by
conformational exchange at the fast-to-intermediate scale (not
shown). Residue 320, in other words, can experience different con-
formations in both DIII-1 and DIII4, but the rates at which it alter-
nates between such conformations appear different in the two cases.
FIG 1 Flexibility of DIII of dengue virus E protein. (A) Ribbon representation of DIII of serotypes 1 (left) and 4 (right). Backbone flexibility is indicated by ribbon
thickness and color. Blue and thin ribbons represent rigidity, whereas red and thick ribbons indicate residues with increased motion. The values for the order
parameter S2 are shown on the structure. S2 is derived from NMR experiments; values range from 0 to 1, with lower values indicating increasing flexibility. (B)
Cartoon representation of DIII, with residues showing conformational exchange in free DIII indicated as light (DIII-1) and dark (DIII-4) blue spheres. Residues
experiencing a different chemical environment at low pH, according to NMR mapping experiments, are shown in green on the structure of DIII-4. (C) Values
for the order parameter S2 shown on the structure in panel A are plotted as a function of residue number, and residues with signal overlap are shown in purple.
(D) NMR-derived Rex values indicating conformational exchange plotted as a function of residue number.
Moraes et al.
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In order to quantify the conformational exchange identified in
DIII, we used Carr-Purcell-Meiboom-Gill (CPMG) relaxation
dispersion NMR spectroscopy (41, 42).R2,eff values obtained from
15N CPMG experiments at 298 K, 303 K, and 308 K showed no
significant difference between the R2,eff values measured with
CPMG frequencies of 50 and 1,000 Hz, meaning that the residues
have a Kex/	 value of1, or a Kex value of2,000 Hz, outside
the time scale range in which it is possible to separate kinetics,
thermodynamics, and chemical shift parameters by fitting the ex-
perimental data with theoretical models (43–45).
The DENV E protein undergoes a profound conformational
change after cell entry, when the pH drops from 7 to 5 in the
endosome. Although the overall fold of DIII remains identical, its
position changes by 70° in relation to the other E protein do-
mains (13, 46, 47). This process involves disruption of specific
interactions between DI and DIII of the E monomer. In particular,
at high pH, E368 on DIII forms electrostatic interactions with R9
in DI, whereas it interacts with H317 of DIII at low pH. Although
we observed DIII only in the absence of the other domains and
thus cannot assess the impact of interactions between different
domains or different E protein dimers on the virus surface, it is still
instructive to compare its behavior at decreasing pHs.
The structural changes in DIII-4 caused by pH variation were
monitored by NMR mapping experiments, measuring the devia-
tions of chemical shifts in 1H-15N HSQC NMR spectra. Briefly, the
chemical shift is extremely sensitive to the local chemical environ-
ment; chemical shift changes therefore indicate local structural or
chemical alterations. Analysis of the CSP index calculated from
experiments carried out at pH 5.5 and pH 7.2 indicates the resi-
dues affected by pH variation (Fig. 1B, green). The residues cluster
in the DIII region close to the neighboring E protein dimer as well
as around H390 in DIII-4 (residues 315, 317 to 321, 376, 377, 390,
and 391). No significant differences between DIII-1 and DIII-4
were noted, which might not be surprising considering that the
pH-dependent mechanism for E protein rearrangement is likely
conserved among serotypes. Despite the chemical shift changes
showing clear differences, the molecular motions of DIII-4 at pH
5.5 and pH 7.2 were very similar, as measured by the transversal
relaxation rates, R2. Thus, the flexibility of the isolated DIII-4 is
not affected by pH variation.
Interaction of DIII with antibody DV32.6. Binding of the
neutralizing human antibody DV32.6 to DIII of each serotype was
previously observed by NMR spectroscopy (27); however, a 50-
kDa Fab version of the antibody (48) was used, whereas in this
work, we used a 25-kDa single-chain version. Our first task, there-
fore, was to repeat the NMR mapping experiments to verify that
the two antibody fragments behave similarly. Indeed, there is very
good agreement among the data collected, with the difference that
the scFv fragment, of a lower molecular mass, provides higher-
quality NMR spectra.
The binding and mapping of residues of DIII-1 and DIII-4
affected by complex formation were monitored by NMR chemical
shift mapping (47). Briefly, the chemical environment of DIII
epitope residues changes upon antibody binding, and so does the
position of their NMR signal (chemical shift). Residues with sig-
nificant chemical shift differences between free DIII and DIII
bound to the antibody are therefore identified as being part of the
intermolecular interface. Several DIII residues showed large
chemical shift variations in 1H-15N HSQC NMR spectra upon
antibody binding, delimiting a contiguous and well-defined re-
gion (Fig. 2 and 3, purple). Other residues, for instance, E311 in
DIII-1, showed broadening and weak intensity upon binding, a
strong indication of conformational exchange in the microsec-
ond-to-millisecond time scale induced by complex formation. As
noted previously (27), NMR mapping showed that the antibody
epitope is only partially accessible on the X-ray structure of the full
E protein, being covered by residues from the other domains in
the neighboring E monomer (Fig. 2C and D) (11).
To further characterize the epitope and to be able to distin-
guish the residues that are directly involved in antibody interac-
tions from residues that are allosterically affected by antibody
binding, we probed the accessibility of DIII residues by a small
paramagnetic molecule. We monitored the effect of the addition
ofthegadolinium-basedparamagneticrelaxationagentGd(DTPA-
BMA) on NMR relaxation. Gd(DTPA-BMA) is uncharged and
highly soluble in water and presents low specific binding to pro-
teins (49). It is expected to enhance the relaxation rates and thus
decrease the NMR peak intensity of the protein amide groups that
are exposed to water and are therefore at the protein surface. In-
terface residues in the antibody-DIII complex are not solvent ac-
cessible, and their signal is thus not disturbed by the presence of
the paramagnetic probe. By comparing the 1H-15N HSQC signal
intensities of the antibody-DIII complex in the presence and ab-
sence of the paramagnetic molecule, it is possible to distinguish
interface DIII residues (signal intensity not altered by gadolinium)
from residues affected by antibody binding (previously identified
by chemical shift mapping) but not directly located at the interface
(lower intensity in the presence of the paramagnetic agent). Re-
sults are shown in Fig. 2.
In general, a very good correlation was found between the CSP
index and the degree of protection against the decrease of intensity
caused by Gd(DTPA-BMA) in solution. Results show that many
epitope residues mapped by CSP are protected from Gd (i.e., the
difference in intensities with and without Gd is zero). On the other
hand, epitope residues such as S353, T388, and W391 (Fig. 2B)
have a significant decrease in intensity in the presence of Gd, sug-
gesting that they are not directly located at the antibody-antigen
interface, but they are probably related to allosteric effects follow-
ing binding. Indeed, these residues are on the opposite face of
DIII-4, away from the antibody-binding site.
Backbone dynamics of DIII in complex with antibody
DV32.6. We analyzed the impact of antibody binding on the flex-
ibility of DIII by comparing the ratio of 15N relaxation rates, R2
and R1, in the presence or absence of antibody DV32.6.
The average R2/R1 ratio values were 4.5 s
1 for the free DIII
domains and22 s1 for DIII-antibody complexes, reflecting the
higher molecular mass of the complex. With regard to internal
molecular dynamics, binding of scFv DV32.6 to DIII-1 led to a
decrease of intensity beyond detection for residues E311, T315,
T321, and Q323 located in the-sheet (ABD); I335 in the BC loop;
and E370 and E375 in the -sheet (CEF). Residues T339, N355,
and Y377 also showed higher-than-average R2/R1 ratio values.
Both effects are a strong indication of changes in the conforma-
tional exchange regime upon binding.
Comparison of the R2/R1 ratios for free DIII-4 and DIII-4 in
complex with scFv DV32.6 indicates that residues V321, E338, and
N360 are in conformational exchange in free DIII-4 but not in the
complex. This could be interpreted as a stabilization of the con-
formation around those residues induced by antibody binding.
Residues V321 and E338 are part of the NMR-characterized
Conformational Diversity in DIII Probed by NMR
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epitope and are directly involved in antibody binding (Fig. 2), so it
is not surprising that they change the conformational equilibrium
and become more ordered in the complex due to intermolecular
interactions. In contrast, residues A358, V364, and N366 broaden
beyond detection in the complex. Also, residues E327 and L357
appear to contribute to conformational exchange in the antibody-
DIII complex but not in free DIII. These residues are highlighted
in the structure of DIII shown in Fig. 3 (yellow and orange).
Taken together, these data suggest that on one hand, antibody
binding reduces the conformational freedom of epitope residues,
which is not surprising, but that on the other hand, it provokes allo-
steric conformational effects on DIII that are not limited to the stabi-
lization of conformational exchange or conformational selection in
the antigen.
It is worth noting that residues of DIII-1 that are involved in con-
formational exchange processes in the complex are localized on both
faces of the DIII structure (-sheets ABD and CEF) (Fig. 3A). In
contrast, in the DIII-4–DV32.6 complex, residues showing move-
ments in the microsecond-to-millisecond time scale are localized on
the protein side formed by -sheet ABD and loops BC and CD
(Fig. 3D). These results indicate not only that DIII-1 and DIII-4 pres-
ent different degrees of motion in the microsecond-to-millisecond
time scale but also that different residues are affected by antibody
binding in the two serotypes, suggesting that the molecular dynamics
of the DIII-1 and DIII-4 complexes with DV32.6 are also different.
DISCUSSION
The importance of protein flexibility in structure and intermolecular
interactions has been recognized in several works (44, 50, 51). Little
has been done, however, to investigate the role of molecular motions
in antibody-antigen recognition despite the attention that these com-
plexes receive in several research fields. One of the reasons for the lack
of available data is that antibody-antigen complexes are large and not
easily accessible by solution NMR spectroscopy, the main tool that
allows residue-level, quantitative analysis of protein dynamics.
Antibodies interact with antigens through six “CDR loops”
with lengths typically up to 20 residues. Flexibility in these loops
might confer broad selectivity to an antibody, i.e., the ability to
recognize and bind different antigens (e.g., virus serotypes), pos-
sibly at the price of higher entropic costs if these loops become
FIG 2 Binding site of antibody DV32.6 on DIII. (A and C) DIII-4 residues affected by antibody binding according to NMR mapping experiments are shown in
purple on the cartoon and surface representation of isolated DIII-4 (A) and on the structure of the full E protein dimer (C). The epitope is only partially accessible
in the context of the dimer. Antigen residues directly located at the intermolecular interface and not accessible to a paramagnetic molecular probe are shown in
green. (B) NMR data used to generate panels A and C, where the CSP index (left scale) is shown as vertical bars versus residue number. A higher CSP index
indicates that a given residue is affected by antibody binding, shown in purple in the chart. Residues directly located at the antibody-antigen interface were
identified by probing their accessibility by a small paramagnetic molecular probe. Right scale shows the difference of intensity in the HSQC spectra of the complex
without or with Gd(DTPA-BMA). Results of this experiment are represented by green circles. Residues with values close to zero (right scale) (the zero value is
indicated by a dotted line) are not accessible to the probe and thus are located either inside the protein or at the intermolecular interface. a.u., arbitrary units. (D)
Cartoon representation of part of the dengue virus surface. The epitope of DV32.6 is shown in purple on DIII. The epitope is mostly inaccessible on the virus
surface, suggesting that antibody binding requires conformational rearrangement. Antigen residues that show conformational exchange in the free antigen are
shown as blue spheres, as described in the legend of Fig. 1.
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rigid upon complex formation. Conversely, CDR loops that are
already rigid might bind antigens with higher affinity and speci-
ficity. Indeed, one view is that naive antibodies might be flexible
and capable of recognizing a diverse antigen repertoire with low
affinity. After maturation, instead, the CDR loops might become
rigid, specific, and highly effective, with binding affinity often
reaching subnanomolar levels.
One question, however, is how high-affinity antibodies can
interact with flexible antigen regions. Does the antigen alternate
between different conformations, one of which is selected by the
antibody? Does the antigen become rigid upon complex forma-
tion, carrying an entropic cost presumably compensated for by the
formation of favorable intermolecular interactions (52, 53)?
Here we investigated the interaction of human antibody
DV32.6, which binds to the four existing dengue virus serotypes
with nanomolar affinity, and domain III of E, the surface protein
of dengue virus.
Dengue virus E protein is a particularly relevant model to study
antigen flexibility because molecular motions are critical for both the
infection cycle (requiring conformational rearrangement involving
DIII) and antibody recognition. On one hand, anti-DIII antibodies
have been shown to bind to epitopes that are not accessible in the
known structures of the virus, suggesting that molecular rearrange-
ments are required to expose them (54, 55); on the other hand, anti-
body binding was shown to either alter the virus structure or trap the
antigen in an already existing conformation (21).
As a first step, we measured the backbone flexibility of the
isolated DIII of DENV serotypes 1 and 4 by 15N relaxation solu-
tion NMR experiments. DIII-1 and DIII-4 showed very similar
dynamics in the picosecond-to-nanosecond time scale, which is
sensitive to reorientational movements of the NH bond and there-
fore characterizes the rotational diffusion and internal motions in
the thermal energy range (39). Residues located in the N and C
termini have higher mobility; the BC, CD, and EF loops also pres-
ent a higher degree of flexibility than residues located in the
-strands. Contributions of movements in the microsecond-to-
millisecond time scale, typically associated with motion and rear-
rangements of specific regions of the protein, are also visible.
FIG 3 Effect of antibody binding on antigen flexibility. Shown are cartoon and surface representations of DIII-1 (A to C) and DIII-4 (D to F). The epitope of
antibody DV32.6 is shown in purple, as described in the legends of Fig. 1 and 2. Residues showing conformational exchange in the free antigen are in dark and
light blue, as described in the Fig. 1 and 2 legends. Residues showing conformational exchange only when the antigen is bound by the antibody are shown in yellow
and orange. In DIII-4 (bottom), the conformational exchange of epitope residues (blue) is eliminated by antibody binding in a process suggestive of conforma-
tional selection. Binding, however, causes conformational exchange in different antigen residues (orange), suggesting that antibody binding can alter the antigen
structure. A similar pattern can be detected in DIII-1, but the residues involved are different.
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However, it is worth mentioning here that DIII-1 and DIII-4 show
many differences in dynamics in this time scale. It is tempting to
think that such differences might have an effect on antibody rec-
ognition of different serotypes. A cross-reactive antibody, in other
words, might have to adapt not only to different primary se-
quences but also to different dynamic behaviors of the antigen.
In DIII-1, nine residues contribute to conformational ex-
change in the microsecond-to-millisecond time scale (Fig. 1B).
None of these residues is involved in conformational exchange in
DIII-4, where 5 other residues are in conformational exchange
(Fig. 1B). These residues are part of the epitope of antibody
DV32.6, discussed below, but are also close to residues that form
interdomain interactions critical for the stability of the E protein
dimers on the virus surface.
Residue H317, for instance, triggers the conformational
changes induced by pH variation after cell entry, when the salt
bridge between E368 and R9 is replaced by the salt bridge E368-
H317 in the low-pH endosomal environment (8, 11, 56, 57). The
resulting disruption of the interdomain interactions leads to the
separation of DIII and rearrangement of the E protein from a
dimeric to a trimeric conformation. The NMR-observed move-
ment regime and conformational exchange of the -strand might
influence the position of H317 and its interdomain interactions,
facilitating the movement of DIII which is required for the low-
pH-induced conformation and to expose the epitope of DV32.6
and other antibodies on the virus surface. Interestingly, in DIII-4,
H390 is close to E186 located in DI of another E protein dimer on
the virus surface. Protonation of this histidine at endosomal pH
might strengthen the interaction through the formation of elec-
trostatic contacts. The histidine is not conserved in other sero-
types, suggesting that disruption of the E protein arrangement
might be more readily achieved.
Antibody DV32.6 (see below) has the peculiarity of binding
strongly to its epitope on the isolated domain III of dengue virus
serotype 4 (equilibrium dissociation constant [KD] of 34 nM) but fails
to effectively neutralize this serotype. In contrast, binding to DIII-1 is
weaker (KD of 145 nM), but this serotype is neutralized by the anti-
body (50% inhibitory concentration [IC50] of 4g/ml). It is possible
that, thanks to the above-mentioned dynamic differences, in the con-
text of the full virus, the DV32.6 epitope is more readily accessible on
dengue virus serotype 1 than on dengue virus serotype 4.
The impact of antibody binding on the structure and dynamics
of DIII-1 and DIII-4 was also assessed by NMR spectroscopy.
Most of the DIII epitope residues, identified by both chemical shift
perturbation analysis and accessibility to a paramagnetic probe,
are located in the patch formed by -strands A, B, and D. When
these residues are analyzed in the context of the full E protein
crystal structures, it is evident that the majority of the epitope is
covered by other domains of the E protein dimer (Fig. 2). Simi-
larly, the epitopes of all other anti-DIII antibodies with a known
structure are partially inaccessible on the virus surface (1A1D-2,
4E11, and 2H12) (20, 54, 55). Conformational changes causing
different degrees of epitope exposure are likely important for the
binding, specificity, and neutralization capacities of antibodies
against the four different serotypes (20, 27, 58).
We obtained a quantitative description of the backbone dy-
namics of DIII in the presence of scFv antibody DV32.6. The val-
ues for the relaxation parameters and for the R2/R1 ratio of the
complex are much higher than those of free DIII-1 and DIII-4, as
expected for a complex with a molecular mass of35 kDa. Bind-
ing of scFv DV32.6 to DIII-1 leads to changes in conformational
exchange mainly in the microsecond-to-millisecond time scale.
Residues that show conformational exchange in free DIII do not
do so in the DIII-antibody complex. This is in line with the idea
that antibody binding can contribute to conformational selection
in DIII, with epitope residues becoming more rigid due to direct
interactions with antibody residues.
Other DIII residues, however, are affected by conformational
exchange even in the antibody-antigen complex. Furthermore,
the residues in exchange occupy different regions of the domain:
whereas they are spread in both the ABD and CEF -sheets in
DIII-1, the residues are clustered on one side of the ABD sheet in
DIII-4. Part of the epitopes of both serotypes is in conformational
exchange in the complex. One possible explanation for this is that
the antibody needs to adapt to different serotypes and thus fails to
form “ideal” contacts with some of the residues, resulting in ex-
change between alternate antigen conformations. For example,
the antibody might be able to establish particularly favorable con-
tacts with E311 in DIII-4 but not DIII-1 (Fig. 3, yellow). Con-
versely, residue N366 might not form specific interactions with
the antibody in DIII-4 (Fig. 3, orange) but might do so in DIII-1.
It is worth mentioning that the binding affinities for the two sero-
types are similar but not identical, with KD values of 34 nM for
DIII-4 and 145 nM for DIII-1 for the full antibody. More surpris-
ingly, other DIII-4 residues (E327, L357, A358, V364, and N366)
that have no conformational exchange in the free protein show
exchange after antibody binding.
Intermolecular contacts between antibody and epitope atoms
alter the degree of freedom available to the latter, resulting in a
change in dynamics. The antibody contributes to making the an-
tigen more rigid at the binding site but actually allosterically in-
creases its flexibility in other regions. At the biophysical level, this
might lessen the entropic requirements of antibody binding, since
the penalty attached to increased epitope rigidity is relieved by
increased flexibility elsewhere. At the biological level, this suggests
that the antibody can alter the structure and dynamics of DIII.
This allosteric effect might contribute to the disruption of the
intermolecular packing interactions on the DENV surface, result-
ing in an altered virus conformation, as seen by cryo-EM for an-
tibody 1A1D-2 (20). The ability of DV32.6 and other DIII anti-
bodies to neutralize DENV might arise from such a disruption of
virus surface packing, resulting in virus inactivation.
Domain III contains epitopes for neutralizing antibodies and
also participates in primary and secondary cell receptor recogni-
tion (59). High-pH-induced interdomain rearrangements involv-
ing DIII are required for virus fusion to the host membrane. DIII
is also a target for the development of vaccines and antiviral
agents. Although recent works have suggested that anti-DIII anti-
bodies are rare and not crucial for the natural immune response to
DENV (60, 61), they are relevant candidates for passive immuni-
zation therapies. Regardless of biomedical interest, DIII remains a
good model for the study of antibody recognition and selectivity,
also thanks to the existence of four main DENV serotypes. Many
studies have provided extensive structural information on E pro-
tein and particularly on DIII, also in complex with antibodies. In
contrast, there is very scarce information regarding the molecular
dynamics of free DIII, and nothing is available on the dynamic
effect of antibody binding, especially at the quantitative level.
In this work, we addressed various structural aspects of DIII
and their importance for the dengue virus infection mechanism
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and antibody recognition. We provided a dynamic description of
free DIII, at physiological and endosomal pHs and in complex
with human antibody DV32.6, which binds to DIII with nanomo-
lar affinity. We observed conformational exchange in the isolated
DIII, in regions important for the packing of E protein dimers on
the virus surface. The relative lack of conformational stability is
likely to facilitate the partial detachment of DIII from the other E
protein domains, which is required to achieve fusion to the host
cellular membranes and to expose the epitopes of various anti-
DIII antibodies. Antibody binding not only removed the exchange
regime in the epitope region, in a process reminiscent of confor-
mational selection, but, somewhat surprisingly, also caused ex-
change in other parts of DIII through allosteric effects.
Protein flexibility is known to play important roles in both
structure and intermolecular interactions. However, its role in
antibody binding is often neglected. One reason for this is that
quantitative dynamic information is very difficult to obtain
through X-ray crystallography, the technique of choice for the
characterization of antibody-antigen complexes. In contrast, so-
lution NMR spectroscopy is perfectly suited to the study of mo-
lecular dynamics and transient structural conformations. This
work provides one of the very rare descriptions of the effect of
antibody binding on antigen flexibility.
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